ACR Appropriateness Criteria® Chronic Liver Disease: 2026 Update
In brief
Updated liver disease guidelines map imaging choices for diagnosis, monitoring and cancer surveillance
The 2026 American College of Radiology guidelines review imaging options for diagnosing chronic liver disease, assessing treatment response and monitoring conditions including iron overload, fatty liver and fibrosis. They draw on current evidence and expert review, but the abstract does not specify which tests are preferred in each scenario, leaving the detailed recommendations to the full guideline.
- Journal
- Journal of the American College of Radiology : JACR (Q1)
- Published
- 19 November 2026
- Study design
- Practice guideline / consensus
- Evidence level
- Level 1, High (CEBM 1c)
- Authors
- Alice Fung, Riham H El Khouli, Gary R Schooler, Donnie Batie, Saeed Elojeimy, Ashwani K Singal, et al.
- PMID
- 43055695
- DOI
- 10.1016/j.jacr.2026.10.007
Why clinicians should know about it
- Picked for Radiology, Radiation Oncology, Nuclear Medicine, Medical Physics and Imaging (top studies of the week, 22 November 2026): Evidence-based guideline for imaging chronic liver disease
Abstract
Chronic liver disease, caused by a range of etiologies, can lead to progressive liver function deterioration, hepatic fibrosis, cirrhosis, and, ultimately, end-stage liver disease. With cirrhosis and end-stage liver disease, complications include portal hypertension, gastrointestinal hemorrhage, refractory ascites, hepatic encephalopathy, and primary hepatocellular carcinoma. Imaging plays an important role in the diagnosis, treatment response assessment, and surveillance of chronic liver disease, specifically of hepatic hemochromatosis, steatosis, and fibrosis, in an effort to prevent progression to cirrhosis. This document reviews the imaging modalities best suited for these clinical scenarios, and a summary of current evidence is provided to support the use of various modalities for each of the clinical contexts. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.